-
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
Frerichs, K. A., Verkleij, C. P. M., Mateos, M. V., Martin, T. G., Rodriguez, C., Nooka, A., Banerjee, A., Chastain, K., Perales-Puchalt, A., Stephenson, T., Uhlar, C., Kobos, R., van der Holt, B., Kruyswijk, S., Kuipers, M. T., Groen, K., Vishwamitra, D., Skerget, S., Cortes-Selva, D., Doyle, M., & 4 others , 9 Jan 2024, In: Blood. 8, 1, p. 194-206 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity
Hiemstra, I. H., Santegoets, K. C. M., Janmaat, M. L., de Goeij, B. E. C. G., ten Hagen, W., van Dooremalen, S., Boross, P., van den Brakel, J., Bosgra, S., Andringa, G., van Kessel-Welmers, B., Verzijl, D., Hibbert, R. G., Frerichs, K. A., Mutis, T., van de Donk, N. W. C. J., Ahmadi, T., Satijn, D., Sasser, A. K. & Breij, E. C. W., 1 Jul 2023, In: eBioMedicine. 93, 104663.Research output: Contribution to journal › Article › Academic › peer-review
-
Improving immunotherapeutic treatment strategies for relapsed/refractory multiple myeloma patients
Frerichs, K. A., 13 Jun 2023, 317 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
- All publications